Cancer Research UK tests first of its kind vaccine to treat lung cancer
A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell…
A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell…
AstraZeneca no longer plans to seek approval of its new respiratory biologic Fasenra in chronic obstructive pulmonary disease (COPD) after the…